“Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review”, Can Dermatol Today, vol. 2, no. s03, pp. 3–8, Mar. 2021, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati